Camber intros generic VascepaIcosapent Ethyl Capsules are indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. Fresenius Kabi obtains FDA OK for biosimilar Tyenne Biosimlar Tyenne is used in the treatment of several autoimmune diseases, including rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis and systemic juvenile idiopathic arthritis. Aurobindo receives FDA nod for generic Myfortic DR Tablets Mycophenolic Acid DR Tablets are indicated for prophylaxis of organ rejection in certain pediatric and adult kidney transplant patients. Sandoz receives FDA approval for Prolia, Xgeva biosimilars Wyost and Jubbonti are interchangeable with and approved by FDA for all indications of Xgeva and Prolia. Aurobindo receives FDA nod for generic Gilenya Fingolimod Capsules are indicated for the treatment of relapsing forms of multiple sclerosis. Lupin names Rakesh Bhardwaj as CIO Bhardwaj has more than three decades of experience in building and managing global IT teams and systems. Aucta debuts generic Vimpat Motpoly XR is approved for the treatment of partial-onset seizures in adults and in some pediatric patients. Camber intros generic Lipitor Atorvastatin calcium tablets are a cholesterol lowering medicine. Camber unveils generic Trileptal Oxcarbazepine Oral Suspension is indicated to treat certain types of seizures. Sandoz U.S. subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffs Sandoz U.S. to pay $265 million in exchange for full release of all claims by the class. First Previous 41 42 43 44 45 Next Last
